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Abstract
Understanding the response of the brain to haemorrhagic damage is important in haemorrhagic stroke and increasingly in
the understanding the cerebral degeneration and dementia that follow head trauma and head-impact sports. In addition,
there is growing evidence that haemorrhage from small cerebral vessels is important in the pathogenesis of age-related
dementia (Alzheimer’s disease). In a penetration injury model of rat cerebral cortex, we have examined the neuropathology
induced by a needlestick injury, with emphasis on features prominent in the ageing and dementing human brain,
particularly plaque-like depositions and the expression of related proteins. Needlestick lesions were made in neo- and
hippocampal cortex in Sprague Dawley rats aged 3–5 months. Brains were examined after 1–30 d survival, for haemorrhage,
for the expression of hyperphosphorylated tau, Ab, amyloid precursor protein (APP), for gliosis and for neuronal death.
Temporal cortex from humans diagnosed with Alzheimer’s disease was examined with the same techniques. Needlestick
injury induced long-lasting changes–haem deposition, cell death, plaque-like deposits and glial invasion–along the needle
track. Around the track, the lesion induced more transient changes, particularly upregulation of Ab, APP and
hyperphosporylated tau in neurons and astrocytes. Reactions were similar in hippocampus and neocortex, except that
neuronal death was more widespread in the hippocampus. In summary, experimental haemorrhagic injury to rat cerebral
cortex induced both permanent and transient changes. The more permanent changes reproduced features of human senile
plaques, including the formation of extracellular deposits in which haem and Ab-related proteins co-localised, neuronal loss
and gliosis. The transient changes, observed in tissue around the direct lesion, included the upregulation of Ab, APP and
hyperphosphorylated tau, not associated with cell death. The findings support the possibility that haemorrhagic damage to
the brain can lead to plaque-like pathology.
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Introduction
Recent advances in cerebral imaging have provided evidence
that haemorrhage occurs in the brain not only in clinically evident
haemorrhagic stroke, but also in clinically ‘silent’ microbleeds or
‘silent strokes’ which, like stroke, occur with increasing frequency
with age [1], and contribute to the dementia of the aged [2,3].
Neuropathological studies [4,5,6,7,8] have provided evidence that
haemorrhage from or dysfunction of cerebral capillaries may be
important in the formation of the plaques characteristic of age-
related dementia (Alzheimer’s disease) [9,10,11], and risk-factor
analyses indicate that age-related dementias are strongly vascular.
Small, clinically silent haemorrhages may be a major factor in the
burden of dementia which afflicts the population in an age-related
pattern.
The present study examines the neuropathology induced in
cerebral cortex of the young, healthy rat by a thin needle
penetrating neocortex and hippocampus. The response of the
cortex to the injury has been examined with immunohistochem-
istry, using techniques which show neuronal death, loss of
synapses, microglial and macroglial proliferation, and proteins
and peptides (APP, Ab, tau) whose expression is considered
important in Alzheimer’s disease. This allows a comparison with
ageing human brain, and a test of the idea that plaques form at the
sites of haemorrhage from cerebral capillaries [4,5,8].
The idea that plaques form where capillaries fail has been
formulated in several ways in prior studies - that plaques form
when capillaries cease to pass blood due to age-related defects in
their structure, creating local hypoxia [12,13,14,15]; or that
plaques form where capillaries lose barrier properties and release
proteins or other substances into the neuropil [7,16]. The present
study tests whether haemorrhagic injury is sufficient to generate
features of senile plaques, and also provides evidence that the area
of direct injury and haemorrhage, and the flanking regions,
respond in distinctive ways, which contribute differently to the
end-stage pathology observed.
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Materials and Methods
Ethics Statement
All research on banked, deidentified human brain tissue was
approved by the University of Sydney Human Research Ethics
Committee. All animal-based research was approved by the
University of Sydney Animal Ethics Committee and was
conducted in accord with guidelines of the National Health and
Medical Research Council of Australia.
Experimental Material from Rats
Sprague Dawley (SD) albino rats of both genders, 3–5 months
old and weighing approximately 300–400 g, were caged in pairs
and kept in a 12 h light (,5 lux)/dark cycle at 22uC. Food pellets
and water were available ad libitum.
Surgical procedure. Rats were anaesthetised with isoflurane
(IsoFlo, Abbott Laboratories, U.S.A) and were given a systemic
analgesic (Rimadyl, Pfizer, 5 mg/kg subcutaneous). The scalp was
shaved and incised along the midline to expose the dorsum of the
skull. The head was placed in a stereotaxic frame and a small hole
(1.35 mm in diameter, located 3.5 mm caudal to the bregma
landmark and 2 mm from the midline) was drilled through the
skull in each side, leaving the dura mater intact. A sterile, thin
(0.64 mm diameter) needle was inserted vertically to a depth of
4.5 mm from the dura, into the cerebral cortex in each
hemisphere. This approach was taken, following [17], so that
the needle would penetrate both the neocortex and the
hippocampus (Figure 1A). The needle was held in place for 5
seconds, and then removed. After completing the needle
insertions, the incision was infiltrated with a local anaesthetic
(2% Lignocaine, Troy Laboratories, Australia) and sutured.
Brain collection, fixation, embedding and
sectioning. Brains were studied from 35 animals, comprising
5 animals at 1 d survival post-lesion, 5 at 3 d, 2 at 5 d, 3 at 7 d, 4
at 14 d, 1 at 19 d and 6 at 30 d, 5 age-matched controls and 4
aged (.12 months) controls. Rats were euthanised by intraper-
itoneal injection of sodium pentabarbitone (60 mg/kg).
Brains collected for immunoblotting (1 at each time point) were
not fixed. Hemi-coronal 2 mm thick slices from the region
including the lesion were made with an ice-cold rat brain slicer
block (BSRAS001-1, Zivic Instruments, U.S.A) and immediately
placed in chilled microcentrifuge tubes, snap-frozen in liquid
nitrogen and stored at 280uC.
Brains for histology and immunohistochemistry were fixed by
perfusion. Briefly, 0.01% heparin sodium salt and 1% sodium
nitrite (Sigma) were injected into the left ventricle. The rats were
then perfused with 0.1 M saline (2 min) followed by 4%
paraformaldehyde in 0.1 M phosphate-buffered saline (PBS) for
10 min. Brains were removed and further fixed by immersion in
4% paraformaldehyde for 3 h. Brains were cut mid-sagittally and
hemispheres cryoprotected in 15% sucrose in 0.1 M PBS
overnight. Hemispheres were embedded in TissueTek OCT
compound (ProSciTech) and cryosectioned at 12 mm in the
coronal plane.
Antibodies used. The antibodies used are listed in Table 1.
Primary antibodies raised in mouse are monoclonal, while those
raised in rabbit are polyclonal.
Western blotting. Tissue slices were homogenised in radio-
immunoprecipitation assay (RIPA) buffer (Millipore) containing
PhosStop (Roche Diagnostics), and 1:100 protease inhibitor
cocktail (Sigma). The homogenate was centrifuged at 12,0006g
for 10 min at 4uC and the supernatant retained.
Protein concentration was determined using the Pierce BCA
Protein Assay kit (Thermo Scientific). Protein samples (50 mg per
lane) and 0.09 ng/ml of Ab 1–40 protein standards (Bachem) were
resolved by SDS-PAGE under reducing conditions, using either
10% Tris-Glycine gels or 10–20% Tris-Tricine gels (Biorad) for
larger (70–100 kDa) proteins and smaller peptides, respectively.
Tris-Glycine gels were blotted to a 0.45 mm PVDF membrane and
Tris-Tricine gels were blotted to a 0.2 mm nitrocellulose mem-
brane. Membranes were blocked in 5% nonfat dry milk in TBS
with 0.1% Tween 20 (TBST) for 1 h. Membranes were incubated
overnight at 4uC with primary antibodies (APP, A11, 6E10, 4G8–
Table 1) followed by 1:3000 HRP-conjugated mouse or rabbit
secondary antibody (Millipore), as appropriate. Blots were
visualised by chemiluminescence detection with an HRP substrate
(Millipore). Blots were stripped with Reblot Plus solution
(Millipore) and probed for glyceraldehyde 3-phosphate dehydro-
genase (GAPDH), to establish internal loading controls. When
probing for Ab monomers and low molecular weight (,25 kDa)
oligomers, nitrocellulose membranes were boiled for 5 min in PBS
immediately after transfer and prior to blocking. A signal boost
(Merck) was used as a diluent for 6E10 and 4G8 antibodies on the
nitrocellulose membranes. Band intensities were measured with
Image J 1.43, and normalised to GAPDH.
Immunohistochemistry. Single immunohistochemis-
try using fluorescent labelling was performed to demonstrate the
antigens Ab, APP, oligomeric Ab hyperphosphorylated tau, using
the antibodies 4G8, 6E10, anti-APP, A11 and AT8. Neurones and
microglia were labelled using monoclonal antibodies against the
markers NeuN (1:100) and CD11b (1:50), respectively. Antigen
retrieval was performed using 90% formic acid (pH 1.6) for
10 min for 4G8, 6E10, and APP antibodies or 80% Reveal It
(ImmunoSolution) in dH2O at 37uC for 20 min for the other
antibodies. Sections were blocked in 10% normal goat serum
(Sigma) in PBS and 0.3% Triton-X 100 (Sigma) before overnight
incubation at 4uC with primary antibodies (Table 1) diluted in 1%
NGS/PBS. Sections were then incubated with 1:1000 goat anti-
mouse Alexa Fluor 488 secondary antibody (Molecular Probes) for
3 h at room temperature or 80 min at 37uC. Sections were
counterstained for nuclear DNA using 1:10,000 bisbenzimide for
2 min (Hoechst).
Single immunohistochemistry using 3,39 diaminobenzidine
(DAB) as the chromogen was performed with the antibodies
anti-APP, 6E10, 4G8, to confirm the observations using immu-
nofluorescence, as well as the anti-tau antibody AT8. Peroxidase
activity in the sections was quenched with 3% H2O2 in 50%
methanol/PBS for 15 min. The sections were then washed and
those to be stained for AT8 underwent antigen retrieval using
0.1 M sodium citrate buffer (75uC for 20 min, then allowed to cool
at room temperature for 45 min). For other antigens, the sections
were processed with formic acid as described above. After
incubating overnight at room temperature with the relevant
primary antibodies, sections were washed in PBS and were
incubated in biotinylated anti-mouse IgG for 1 h followed by
extravidin peroxidase (1:1000; Sigma E2886) for 2.5 h. The
sections were then washed and developed with DAB (0.5 mg/ml,
3–5 min in 0.003% hydrogen peroxide) as the chromogen.
Double immunohistochemistry was used to show the co-
occurrence of monomeric Ab, oligomeric Ab or APP and a second
protein, either the intermediate filament GFAP, a marker of
astrocytes, or synaptophysin, found in synaptic vesicles. Sections
were treated in 90% formic acid (pH 1.6) for 10 min for antigen
retrieval before blocking in 10% NGS. Sections were incubated
overnight at room temperature with a mixture of one mouse
monoclonal antibody (to APP or Ab) and one rabbit polyclonal
antibody (to GFAP, synaptophysin or oligomeric Ab), diluted in
1% NGS/PBS. Sections were then incubated in a mixture of
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Alexa Fluor-488- and Alexa Fluor-594-tagged secondary antibod-
ies specific to the primary antibodies’ host species. Following
secondary antibody treatment, sections were counterstained with
bisbenzimide. Fluorescent images were collected using a Zeiss
deconvolution system, and were analysed using ImageJ software
(National Institute of Health, USA).
Negative controls were routinely prepared by following all
the above steps, but omitting the primary antibodies.
TUNEL staining. To detect apoptotic cells, sections were
labelled with the TUNEL technique [18] to identify fragmentation
of DNA characteristic of dying cells, following published protocols
[19]. Briefly, sections were washed in terminal deoxynucleotidyl
transferase (TdT; Roche) buffer for 10 min at room temperature
and then in a reaction mix of TdT (0.03 enzyme unit/ml) and
biotinylated deoxyuridine triphosphate (dUTP; 4 enzyme unit/ml;
Roche) for 60 min at 37uC. The sections were then incubated with
a stop reaction containing 300 mM NaCl and 30 mM sodium
citrate for 15 min at room temperature. Sections were blocked for
nonspecific binding in 10% NGS for 15 min and then incubated
for 30 min at 37uC with streptavidin-conjugated Alexa Fluor 594
(1:1000), followed by counterstaining with bisbenzimide. For some
sections, the TUNEL reaction was followed by single immuno-
histochemistry, as described above, with Alexa 488 as the
reporting chromophore.
Counts of TUNEL+ profiles were made at 206magnification
along the needle track in both the hippocampus and the
neocortex, from at least five sections from each brain hemisphere.
The counts were averaged and expressed in TUNEL+ profiles/
mm along the needle track.
Staining for iron. The Prussian blue (Perls) reaction was
used to identify iron deposits in the brain, to detect sites of
haemorrhage. Frozen sections were rinsed in 70% ethanol and
placed in a solution comprising equal portions of 4% HCl and 4%
potassium ferrocyanide for 30 min at room temperature. They
were then washed in distilled water for 5 min, and incubated in
1% neutral red solution for 3 min, as a nuclear counterstain.
Congo red and thioflavin staining. Selected sections
labelled with the Perls reaction were second-labelled with either
1% Thioflavin S (Sigma) for 5 min (following [20]) or with Congo
Red (Sigma, Putchler’s modification [21,22]). Briefly, sections
were treated with 2.9 M sodium chloride in 0.01 M NaOH for
Figure 1. The needlestick lesion. A: Coronal section of rat brain, ,3 mm anterior to bregma, stained with Thionine [74]. The arrow and dotted
line show the targeted position of the needle track. The track traverses neocortex (nc) and hippocampus, from CA1 across the dentate gyrus and CA3.
The blue rectangle shows the area imaged at higher power, from an experimental animal, in B. B: Needle track crossing layers of the hippocampus, in
the region marked by the rectangle in A. The track is evident as a string of Prussian-blue labelled deposits, close to a linear break in the neuropil.
Neutral red counterstain. Py – pyramidal layer of CA1; Rad - stratum radiatum of CA1; MoDG – molecular layer of the dentate gyrus; GrDG – granular
layer of the dentate gyrus.
doi:10.1371/journal.pone.0059740.g001
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20 min and staining with filtered 0.2% Congo red in alkaline
sodium chloride solution for 1 h.
Human Material
Source. Human postmortem tissues from cases with a
diagnosis of Alzheimer’s disease, without a clinical history of
stroke, were obtained from the Sydney Brain Bank. The tissue
comprised cerebral cortex from the temporal and parietal lobes,
from 4 cases aged 69–100 years, at stages V and VI of the diseases
[23]. The material had been fixed and stored in 4% formalin.
Cryosectioning and immunohistochemistry. Blocks of
cortical tissue were cryosectioned coronally at 40 mm and free-
floating sections collected. Using the protocols described above,
sections were immunolabelled for Ab and its precursors (4G8 and
6E10 antibodies), for oligomerised Ab (A11 antibody), for APP, for
the astrocyte-specific intermediate filament protein GFAP, and for
tau.
Prussian blue labelling combined with Thioflavin S or
congo red. Labelling for haem-derived iron was carried out as
described above, with two forms of enhancement. Briefly, some
free-floating sections were first incubated in 4% HCl and 4%
potassium ferrocyanide for 30 min, followed by enhancement with
diaminobenzidine (0.67 mg/ml in TBS) and hydrogen peroxide
(final dilution 0.001%) for 5 min. These sections were second-
labelled with either Thioflavin S or with Congo Red, as described
above. Other sections were incubated for a much longer period
(56 h) in the same HCl and ferrocyanide solution, following [4],
and then counterstained in 1% Neutral Red solution for 5 sec.
Thin (0.2 mm) sections and immunohistochemistry. A
variant of the ‘‘array tomography’’ technique of Micheva and
Smith [24] was used with immunolabelling on adjacent thin
sections, imaging to maximise the information obtained from
autofluorescence. Blocks (2 mm cubed) were cut from the parietal
neocortex (84 years, Stage V–VI) and embedded in resin. Serial
sections were cut at 200 nm using a diamond knife (Histoknife,
Diatome, AG Biel Switzerland) and collected on water droplets on
10-cell Teflon-coated slides (ProSciTech, Australia), one section
per drop. Slides were dried at 60uC and stored at 4uC.
The series used here extended for 250 sections (50 mm). Sections
were collected separately and stained individually. To minimise
ambiguities arising from co-localisation and autofluorescence, only
single-label immunohistochemistry was performed on this mate-
rial. Sections were blocked for 30–60 min in 5% NGS before
incubation (3–4 h at room temperature or overnight at 4uC) in
primary antibodies diluted in 5% NGS (usually 1:100). Sections
were then incubated in AlexaFluor secondary antibodies (1:2000)
for 1 h at room temperature, followed by counterstaining with
bisbenzimide.
We also assessed autofluorescence, which is rich in ageing brain
tissue. Yellow- or reddish-brown autofluorescence is exhibited by
lipofuscin/lipopigment [25] and/or haemosiderin [26] granules,
while blue or violet fluorescence is exhibited by senile plaques
[27,28], elicited by UV or violet (405 nm) illumination and
believed to stem from Ab peptide or a closely associated plaque
constituent.
Imaging. To construct montages, sections were viewed using
a Cytoviva (Cytoviva Inc., Auburn, AL, USA) dark field condenser
system with Dual Mode Fluorescence module on an Olympus
BX31 microscope with a 40X NA 0.75 UPlan FLN Olympus
objective and an Exfo X-Cite 120 light source. The emission filter
was a 3 colour multiband (440–470, 520–545, 610–645 nm) filter,
and the excitation filter was also a 3 colour multiband (390–410,
480–510,560–590), except for a very few cases in which the Alexa
488 signal was relatively weak, when a single band 480–510
excitation filter was used with the same emission filter. Images
(24 Mb, 204862048 pixel, 14 bit) were taken with a SPOT Flex
Mosaic colour camera (Diagnostic Instruments, MI, USA),
operated in ‘‘4-shot’’ mode with a total exposure time of 20 sec
and a gain of 1. Approximately 50 overlapping images were taken
for each section. In Adobe Photoshop, the images were treated
with a high pass filter and the intensity histogram adjusted before
overlaying manually to produce a single montage for each section.
Results
The target needle track, shown in Figure 1A on a coronal
section of the rat brain (corresponding to ,3.8 mm posterior to
Table 1. Antibodies used for Western Blotting (WB) and immunohistochemistry (IHC).
Antigen/name Epitope/Clone Host species
Working dilution
IHC/(WB)
Supplier & Catalogue
no.
Primary Antibodies Alzheimer precursor protein N-terminal pre-A4/22C11 Mouse 1:200 (2500) Millipore MAB348
b-Amyloid Ab1–16/6E10 Mouse 1:500 (1000) Covance SIG39320
b-Amyloid Ab17–24/4G8 Mouse 1:500 (1000) Covance SIG39220
Ab oligomers Prefibrillar oligomers/A11 Rabbit 1:1350 (500) Millipore AB9234
CD11b OX-42 Mouse 1:50 Millipore CBL1512
GFAP 2 Rabbit 1:1000 Dako Z0334
Neuronal Nuclei (NeuN) A60 Mouse 1:100 Millipore MAB377
Synaptophysin p38 Rabbit 1:200 (10000) Dako A0010
Phosphorylated Tau AT8 Mouse 1:500 Innogenetics 90206
GAPDH 2 Mouse/Rabbit (1:3000) Sigma G8795/9545
Secondary Antibodies Alexa Fluor 488-conjugated Mouse IgG Goat 1:1000 Molecular Probes A11029
Alexa Fluor 594-conjugated Rabbit IgG Goat 1:1000 Molecular Probes A11037
Biotinylated Mouse IgG Goat 1:200 Vector BA9200
HRP-conjugated Mouse/Rabbit IgG Goat (1:3000) Millipore AP308/307
Working concentrations for Western Blotting are indicated in brackets.
doi:10.1371/journal.pone.0059740.t001
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bregma [17]), traverses neocortex and hippocampal cortex,
including the junction of the dentate and hippocampal gyri.
Figure 1B shows an area equivalent to that boxed in Figure 1A
from one experimental brain, with the needle track crossing the
granule layer of the dentate gyrus. The dark labelling is the Perls/
Prussian blue reaction for iron, showing that the residue of
bleeding induced by the needle was closely restricted to the track.
Also evident with this labelling is a physical split in the tissue;
overall the pathology induced by the needle seems confined to
within 100 mm either side of the track.
Tested with other labels (below), the pathology along the needle
track was dominated by long-lasting features - haem deposition,
neuronal death, gliosis and the formation of plaque-like extracel-
lular deposits of autofluorescent material. In the flanking regions,
the reaction of the tissue was transient and reversible; we observed
the transient intracellular upregulation of Ab and/or APP (labelled
with the 4G8 or 6E10 antibodies), of Ab oligomers and of
hyperphosphorylated tau. The 4G8 and 6E10 labelling was
prominent, in neurones and astrocytes, confirming earlier studies
[29]; in our material, labelling with these two antibodies was
essentially identical. Cell death was not detected in the flanking
regions, except where the needle passed through the pyramidal
layer of the hippocampus.
Along the Track
The Perls (Prussian Blue) reaction labels iron moieties released
into the tissue by the injury, presumably as a result of
haemorrhage. This labelling appeared relatively diffuse at day 1
(not shown). By day 3, presumably as a result of the action of
phagocytotic micro- and macroglia (below), the blue deposits were
more granular and compact (Figure 2A). By day 7, they appeared
dark blue and condensed (Figure 2B), and they retained this
appearance at the longest survival examined (30 d, Figures 2C, D).
Spatially, they were confined closely to the needle track
(Figure 1B).
Extracellular deposits (ECDs) formed along the needle track;
they were first detected at day 7 (Figure 2E) and persisted until day
30 (Figures 2F–H). They were similar in size to the Prussian blue-
labelled deposits (,50 mm in diameter) and to human senile
plaques (below). In material labelled with the 4G8 or 6E10
antibodies (which label APP and Ab), these ECDs fluoresced
brightly. Their fluorescence may arise from autofluorescence of
lipofuscins that have accumulated subsequent to the haemorrhage
and tissue destruction caused by the injury, and from specific
labelling with 4G8 or 6E10. To test this point, the following
analysis was undertaken. We labelled a section showing ECDs
with 4G8, with an antibody to GFAP and with bisbenzimide,
which labels DNA (to demonstrate cell nuclei) (Figure 3C). A
neighbouring section, labelled by the same protocol but omitting
the primary antibodies, served as a negative control (Figure 3A).
Using Image J we sampled fluorescence intensities along sampling
lines crossing ECDs in the negative and positive samples; the
sampling lines used are shown in Figures 3B and D. Immunohis-
tochemistry with the 4G8 antibody using a non-fluorescent marker
(Figure 3F, G) also showed evidence of specific labelling of Ab
and/or APP deposits along the needle track. The dark labelling in
G, compared to the negative control material in F, again suggests
deposits distributed along, but limited to the track.
The intensity profiles obtained along the tracks shown in
Figure 3B,D were analysed in two ways. When intensity was
plotted against distance, it can be seen that in the negative control
material, red and green signals largely co-varied (Figures 4A, B),
while the blue signal showed independent changes. This suggests
that the ECDs emitted at similar intensities in the red and green
ranges (suggesting autofluorescence), while the blue emissions
represented the positive labelling of DNA (cell nuclei) with
bisbenzimide. In the positive labelled material, by contrast, the
fluorescence/distance graph (Figure 4C) shows independent green
and red peaks, and the green vs red plot (Figure 4D, grey symbols)
is distinct from Figure 4C. Many sampling points showed high red
values and low green values (red arrow), and many points showed
high green values and low red values (green arrow). The former
are from the labelling of GFAP in astrocytes; the latter (we argue)
are from 4G8 labelling of ECDs. One negative result should be
noted. Congo Red and Thioflavin S did not label the Ab+ deposits
in rat brain, in contrast with human senile plaques (below).
Labelling with the AT8 antibody gave evidence that the
extracellular deposits that form along the track also contain
hyperphosphoryated tau (Figure 5I, J). Like haem+ and Ab+
deposits, the AT8+ deposits also appeared first at 7 d, and
remained prominent at 30 d, suggesting that some deposits could
contain all three antigens.
The death of neurones along the needle track was assessed in 3
ways. TUNEL labelling showed dying (fragmenting DNA labelled
red) cells along the needle track (arrows in Figure 5G). When
labelling was quantified, as the number of TUNEL+ profiles per
millimetre of track, cell death appeared greatest at 1 d survival (the
earliest time point examined), the number of TUNEL+ (dying) cells
then falling steadily, reaching background levels by day 19
(Figure 5H). In addition, labelling with an antibody to synapto-
physin (Figure E,F) and with the antibody NeuN (specific for the
nuclei of neurones, Figure 5C) shows that synaptic labelling was
decreased along the needle track (between the asterisks in
Figure 5E, across the double-headed arrow in Figure 5F), and
that neuronal cell bodies were absent from the site of the track
(Figure 5C). That is, neurones and some of the synapses they form
appeared to be destroyed by the lesion.
Figure 5G was chosen to show that in the hippocampus, cell
death (red TUNEL+ nuclei) was observed to extend beyond the
site of the track, in the granule cell layer of the dentate gyrus
(towards the bottom left in Figure 5G), but not in other layers of
the hippocampal cortex, or in the neocortex. This was observed in
2 brains, 3 and 5 d post-lesion.
Despite the severe loss of neurones along the track, the site
appeared cellular, when viewed with a DNA label, such as the
nuclear fast red labelling in Figure 5A, suggesting that the site was
re-populated. The cells that repopulate the neurone-depleted site
include microglia (shown with the CD11b antibody in Figure 5D)
and astrocytes (Figure 5B). This repopulation was evident by 3 d
post-lesion; glia became a prominent and stable feature of the
lesion by 7 d.
Oligomerisation of Ab is considered to be a step to the
formation of insoluble deposits of amyloid [30] and many studies
[31,32,33] have reported that the soluble, oligomerised forms are
neurotoxic. In our material, at 1–3 d after the needlestick,
oligomerised Ab was detected with the A11 antibody along the
needle track (Figure 6A). It did not appear to concentrate in
ECDs.
Along the Flanks of the Track
Previous studies have noted that focal lesions to brain tissue
induce transient upregulation of APP and Ab at the margins of the
directly affected tissue [34] and upregulation of hyperpho-
sphorylated tau has been reported within 24 h of traumatic brain
injury in humans [35]. We observed similar changes in tissue
flanking the needle track.
The most striking feature of the regions flanking the needle
track was the prompt increase of 4G8 or 6E10 labelling in cells on
Cerebral Haemorrhage and Plaque Formation
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the flanks of the track (Figure 7A); as Table 2 shows, this
upregulation was transient, limited to ,7 d. APP was also
expressed promptly and transiently in these flanking regions
(Figure 7B, Table 2). Using a non-fluorescent marker (Figure 7F)
we obtained evidence of upregulation of hyperphosporylated tau
intracellularly, in neurones flanking the needletrack. This
upregulation was also transient, limited to ,7 d (data not shown).
Within GFAP+ cells, presumably astrocytes, 4G8 labelling was
present in the somas and extended along processes (Figures 7C,
D). Within the cytoplasm of neurones, the labelling appeared
diffuse, and unattached to intracellular organelles. APP labelling
was also apparent in the somal cytoplasm of neurones and, in
more punctate form, along the GFAP+ processes of astrocytes
(Figure 7E). This upregulation was detected at 1 d post-lesion,
peaked at 3 d and had subsided by 7 d.
Along the flanks of the needle track, the A11 antibody for
oligomerised Ab labelled many small punctate structures, and
occasionally larger (up to 10 mm), more complex structures,
apparently in the neuropil (Figure 6 B,C). This is consistent with
earlier descriptions of oligomerised Ab forming in synaptic
terminals [33,36,37]. Larger labelled structures were also observed
near human plaques (Figure 6D).
In neocortex, we observed dying (TUNEL+) cells only along the
needle track (above). As already noted, TUNEL+ cells were
observed in the flanking regions only in the hippocampus, where
the needle penetrated the densely packed pyramidal layer
(Figure 5G). Many authors have noted the relative vulnerability
of hippocampal neurones to stress in various forms (reviewed [38]).
The increased density of astrocytes at the needle track also
extended into the flanking regions (Figure 5B). Nevertheless,
micro- and astrogliosis were most prominent at the needle track,
suggesting that the gliosis is a response to the neuronal death and
haemorrhages caused at that site.
Time Course of Pathological Changes
Summary of neuropathology. Table 2 summarises several
features of neuropathology observed. Antigens considered impor-
tant in age-related dementia (hyperphosphorylated tau, APP, Ab,
oligomeric Ab) were prominently upregulated in neurones and glia
along the flanks of the track for 1–7 d post lesion; this upregulation
Figure 2. Formation of haem deposits and fluorescent deposits after needle stick lesion. A–D: Prussian blue-labelled (haem) deposits, 3–
30 d after lesion. Deposits formed along the needle track, and were tightly confined to the track. They were relatively diffuse at 3 d, and became
dense by 7 d. E–H: Fluorescent deposits along the needletrack 7–30 d after the lesion. Like haem deposits, the fluorescent deposits were distributed
along, and confined to the needle track (H). The red label shows synaptophysin labelling in E, and astrocytes (GFAP) in F–H. The GFAP labelling is
tightly confined to the needletrack in H. The blue fluorescence is bisbenzimide labelling of nuclear DNA. The needle track in H is through the
hippocampus; GrDG indicates the granule layer of the dentate gyrus.
doi:10.1371/journal.pone.0059740.g002
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was transient, fading after 7 d. Gliosis, the migration and/or
proliferation of microglia and astrocytes, was detectable at day 3
and increased thereafter, outlasting the upregulation of Ab-related
antigens. Cell death assessed with the TUNEL technique was
maximal in the first few days after the lesion, and slowed
thereafter. Iron, presumably derived from circulating haemoglo-
bin, was detected along the needle track at 1 d; iron deposits
increased in compactness and size to 14 d and remained
prominent at 30 d. The formation of ECDs was detected at 7 d
and remained prominent at 30 d. In summary, the needlestick
lesion induced a prominent but transient upregulation of
hyperphosphorylated tau and Ab-related antigens in cells on the
flanks of the track; and several permanent changes (gliosis,
neuronal loss, haemorrhage and formation of ECDs) along the
track.
Western blots. A Western blot using the 4G8 antibody,
which labels Ab and its precursors, confirmed one element of the
time course shown in Table 2. In Figure 8A, 4G8 labelling of
species at 20 kDa, 15 kDa and 12 kDa represent oligomers of
monomeric Ab (4 kDa). These bands reflect an upregulation
(above control) at 1 d, 3 d (peak) and 7 d and then a return
towards control levels. Twin bands were detected at 122 kDa,
corresponding to the size of APP. A comparable blot for
oligomeric Ab, with the A11 antibody (Figure 8B), also showed
upregulation of a 100 kDa immunoreactive species at 1–3 d, but
persisting longer, to 30 d (Figure 8C).
Comparison with Human Senile Plaques
Figure 9A shows plaques in the neocortex (temporal lobe) of an
AD case, labelled with the 4G8 antibody. Plaques are present in all
layers of the cortex, being relatively sparse in layer II; they are also
Figure 3. Analysis of antibody-specific fluorescence vs. autofluorescence. A, C: Neighbouring sections through a needle track 30 days after
the lesion. In A, no primary antibodies were used; these are negative controls. In C, antibodies for GFAP (red) and APP/Ab (green) were used. Exposure
times, excitation intensities and all other settings were held constant between A and C. Scale bar in C also applies to A, B and D. Blue fluorescence is
bisbenzimide staining of nuclear DNA. B, D: The green fluorescence in A and C is shown in white. Sample lines used for the analysis in Figure 4 are
shown, traversing the fluorescent bodies. F, G: Neighbouring sections through a needle track 30 d after the lesion, showing endogenous peroxidase
activity in negative control material; and specific labelling with the 4G8 antibody (which labels APP and Ab) along the needle track. Scale bar in G also
refers to F.
doi:10.1371/journal.pone.0059740.g003
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present, but sparse, in the white matter, confirming earlier studies
[5]. Many are rounded in shape; several large plaques are aligned
along a relatively large vessel in layer IV-V (arrow). The largest are
,50 mm in diameter.
Viewed with a DNA label included (Figure 9B), plaques
appeared highly cellular, containing nuclei with normal chromatin
and TUNEL2 (data not shown). As previous reports have noted,
many of the cell nuclei found in plaques are of glial cells; Figure 9B
shows that astrocytes (immunolabelled red) are present in and
around the plaque. Endothelial cells of blood vessels are also found
within the 4G8+ regions of plaques (Figure 10). These nuclei do
not appear pyknotic or degenerative, suggesting that the environ-
ment is not cytotoxic.
Plaques show a strong concentric organisation. Figures 9B and
10 F,G show this concentric organisation for a single plaque; it was
commonly observed (Figure 9C). The APP/Ab2 (4G82) labelled
material seems to form a shell, inside which some nuclei and
autofluorescent bodies, perhaps lipofuscins and/or haemosiderin,
are found. In favorable preparations, evidence could be seen of an
incomplete shell of APP (Figure 10F) or GFAP+ (astrocytic)
structures (Figure 9B) external to the shell of Ab.
Confirming previous studies [4,9], we noted that many plaques
formed in close relationship to small blood vessels. In Figure 10A–
E, the five panels are from adjacent sections through the same
plaque, which has formed around the branch point of capillary-
sized vessels. Figures 10A and 10B show the plaque by
autofluorescence (blue autofluorescence of plaques has been
described previously and attributed to Ab [27,28]); Figures 10C
and 10D show the same plaque immunolabelled with 4G8, in
sections 8 mm away; and Figure 10E shows that small elements of
tau are present in the plaque. Figures 10F,G show adjacent
sections of another plaque from the same case. In F, the plaque is
autofluorescent and APP is labelled red, by immunohistochemis-
try. Panel G shows the same plaque immunolabelled with 4G8,
and demonstrates a small capillary-sized vessel, with an endothelial
nucleus adjacent (inset), inside the 4G8+ shell. Not every section
through a plaque showed a blood vessel, but a close relationship
was common. A statistical analysis of the spatial relationship of
plaques to vessels is reported in [4,5].
Figure 4. Analysis of antibody-specific fluorescence vs. autofluoresence. A, B: A shows the variation of red, green and blue fluorescence in
negative control sections (along the line shown in Figure 3B). The blue fluorescence is bisbenzimide labelling of nuclear DNA; the red and green
fluorescence is autofluorescence. B shows that red and green fluorescence levels co-vary. C, D: C shows the variation of red, green and blue
fluorescence in the section in Figure 3C, along the line shown in Figure 3D. This material was labelled for GFAP (red), amyloid (green) and nuclear
DNA (using bisbenzimide). D shows the red vs green plot for points along the line in Figure 3D. The dark points reproduce the co-variance seen for
negative control material in B. The red and green arrows indicate points that show high red fluorescence (GFAP) and high green fluorescence
(amyloid).
doi:10.1371/journal.pone.0059740.g004
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A key point in Cullen and colleagues’ [4,5] conclusion/
hypothesis that plaques form at the site of microhaemorrhages
was evidence that the plaque-ridden brain is ridden also with small
deposits of haem, detected with the Prussian blue/Perls reaction,
which co-localise with plaques. We searched for this co-localisation
using the Prussian blue reaction to detect iron and amyloid-
binding dyes. As noted by Cullen and colleagues [5], it is difficult
to test this co-localisation using immunohistochemistry, because
the high acidity of the Prussian blue reaction destroys antigens.
Figure 11A shows a human plaque labelled for Ab with Congo
Red, and for haem using the Prussian blue reaction, with DAB as
the reporter reaction. When the peaks of Congo red labelling were
isolated (Figure 11B) it was apparent that the major site of Prussian
blue labelling was surrounded with a ring of Congo red; and that
several smaller Prussian blue granules were also related to Congo
red labelling. Figure 11C shows another example of the close
apposition of haem and amyloid, in a plaque, using Congo red.
Figure 11D shows the same relationship for a group of plaques,
this time with the amyloid labelled green with Thioflavin S, again
selecting the peaks of dye labelling.
Discussion
The present experiments show that a penetrating injury of the
cerebral cortex creates distinct neuropathologies along the track of
penetration, and in the tissue that flanks the track. Along the track,
Figure 5. Neuropathology of needlestick lesion. The arrows indicate the locus and direction of the needle track. The blue labelling in B to E and
G is bisbenzimide labelling of nuclei. A–E: Neighbouring sections of neocortex 30 d after the lesion showing haem deposition (A, Perls reaction on a
Neutral Red counterstained background); astrogliosis (B, GFAP labelling) along the track and spreading beyond it; the loss of nerve cells along the
track (C, NeuN labelling); microgliosis along the track (D, labelling with CD11); loss of synaptophysin labelling along the track (E); quantification of
synaptophysin labelling (F) along the line in E between the asterisk. G: Most cell death (labelled red with the TUNEL technique) was concentrated
along the needle track (arrows), whether in neocortex or hippocampus. This image shows the only exception observed - TUNEL labelling shown here
in the granule layer of the dentate gyrus, extending laterally (to the left) from the track. The 4G8 antibody has also been applied (green). H:
Quantification of TUNEL+ (dying) cell nuclei along needle tracks through neocortex and hippocampus, as a function of survival time (5 sections
counted per time point, error bars showing standard errors of the means). I, J: AT8 labelling of hyperphosphorylated tau in extracellular deposits
along a needle track in neocortex, with DAB as the reporting chromagen (J is the negative control for I).
doi:10.1371/journal.pone.0059740.g005
Figure 6. Immunohistochemical localisation of oligomeric Ab, 3–5 d post-lesion (A,B,C) and near a human plaque (D). Blue
fluorescence is bisbenzimide labelling of nuclear DNA. A: In favorable sections A11 labelling (red) could be seen along the needle track. The green
fluorescence is autofluorescence, most marked in blood vessels. B, C: Further from the track, A11 labelling was often punctate, but small crystal-like
structures were also labelled, as previously reported [36,37]. D: A11 labelling in human neocortex was also often punctate, but larger crystalline
structures were seen, usually away from or (as here) at the edge of a plaque. The green label is 4G8 (Ab and precursors).
doi:10.1371/journal.pone.0059740.g006
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there is mechanical disruption of tissue, loss of neurones and
synapses, microglial proliferation/invasion and the extracellular
formation of haem+, hyperphosphorylated tau+ and APP/Ab+
deposits, all long-lasting changes. In the flanking regions, which
can be compared with the penumbra of ischaemic tissue which
surrounds an intracerebral haemorrhage [39], there is little or no
loss of neurones (except in the pyramidal layer of the hippocam-
pus); the most prominent changes are the upregulation of
expression of APP/Ab and hyperphosphorylated tau; and these
upregulations are intracellular and transient.
Implications
The changes that occur along the track resemble the plaques
and neuritic tangles found in the ageing human brain, associated
with dementia. In particular, the extracellular deposits which
formed along the track were similar in size (up to 50 mm), were
surrounded and invaded by microglia and macroglia (astrocytes),
were labelled by antibodies (4G8, 6E10 and AT8) for APP, Ab and
hyperphosphorylated tau, and contained and were surrounded by
oligomerised Ab. Further, extracellular deposits of haem+ material
also formed along the track, suggesting co-localisation of haem and
Ab+ deposits, as reported for human senile plaques [4,5] and
confirmed in Figure 9.
The present results allowed as a test of the prediction, arising
from a specific hypothesis of senile plaque formation [5,8], that
haemorrhage can induce the formation of plaque-like deposits in
the otherwise healthy brain. The co-occurrence of deposits of
haem and APP/Ab+ deposits, both narrowly confined to the
penetration track (Figures 1, 2), provides support for this
prediction, although it does not, of course, prove causation.
It can be noted, however, that where there is no haemorrhage,
plaque-like deposits do not form. In the present experiments, for
example, the upregulation of APP and Ab in tissue on the flanks of
the penetration track is an established marker of brain trauma
[40,41,42,43]. The flanks responded to the penetration, but
haemorrhage did not extend to the flanks, and extracellular
deposits did not form there. Several earlier reports also support
this negative correlation (no haemorrhage, no plaque-like struc-
tures). For example, non-haemorrhagic ischemia induces brain
damage and cognitive loss comparable to human dementia,
without the formation of plaques [14,15,44]. Correspondingly, in a
model of ischaemic stroke in the Tg2576 mouse (in which the
transgene causes plaque formation [45]), ischaemia without
haemorrhage did not increase the formation of Ab+ plaques. In
humans, most cases of stroke are non-haemorrhagic [46], and
plaques are not associated with the resultant brain damage and
dementia.
Figure 7. Immunohistochemical localisation of tau, APP, Ab and precursors, at 3 d post-lesion. A: The needle track is marked by arrows.
On each side of the track, 4G8 (green) labelling (of Ab and its precursors, including APP) is upregulated in the somas of neurones and astrocytes, for
up to 200 mm. The red labelling is GFAP (astrocytes). B: In an adjacent section, APP labelling (green) is also upregulated along the flanks of the track.
Labelling with the APP antibody appears more extensive than with the 4G8 antibody, suggesting that 4G8 shows some selectivity for Ab. C: Left and
right panels show labelling for GFAP and for both GFAP and 4G8, at higher power. The GFAP+ cells (astrocytes) are also 4G8+. D: Left and right panels
show labelling for GFAP and for both GFAP and 4G8, at higher power. Neuronal somas (larger, rounded, GFAP2) are strongly 4G8+ (green). E: APP
labelling (green) is found in neuronal somas and co-localises with GFAP (red) in astrocyte processes. F: Immunolabelling for hyperphosphorylated tau,
at the edge of a needle track in neocortex. The arrow marks the needle track; labelling with DAB. The scale in A applies to B; the scale in D applies also
to C and E. Blue is nuclear DNA labelled with bisbenzimide.
doi:10.1371/journal.pone.0059740.g007
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In their review of the neuropathology of human stroke,
Hossmann and Heiss [46] write that most spontaneous intra-
cerebral haemorrhages occur in deep hemispheric structures (so
not in the cortex) and in small arteries. If it proves correct that
plaques form at sites of bleeding from cortical capillaries, as argued
by [5,8], these conclusions may need to be updated. That is,
intracerebral haemorrhage may be much more common than
indicated by the aetiology of stroke; may be much more common
in the cerebral cortex than in deeper structures; and may occur
most frequently in capillaries, rather than small arteries.
Figure 8. Amyloid-related protein expression in needle stick brain tissue. A: Western blot of tissue near and including a needle track,
labelled with the 4G8 antibody (which labels Ab peptide and precursor molecules such as APP). Protein samples (50 mg/lane) were processed from
animals surviving 1 d, 3 d, 5 d, 7 d, 14 d and 30 d after the lesion. Lane C shows a sample from an unoperated (age-matched control) brain. Labelling
at 4 kDa (monomeric Ab) was not obtained. Twin bands were observed at 122 kDa, corresponding to the size of APP. Labelling at molecular weights
characteristic of oligomers was obtained (20/15/12 kDa). These bands showed intensification above control (C) levels, most prominently at 3 d and
7 d. As expected, a 4 kDa band was observed for the Ab1–40 standard. B: Western blot of the same tissue, using the A11 antibody (which labels
oligomeric Ab). A11 labelling identified a single band at 100 kDa, presumed to be a pre-fibrillar form of oligomeric Ab. GAPDH (37 kDa) was used as a
loading control. C: Densitometry analysis of the A11 labelling in B, normalised to GAPDH. Labelling (for oligomeric Ab) shows limited upregulation at
3 d and 5 d, and again in the older animals (A1 and A2). Error bars represent standard error of the mean, n = 4 separate experiments.
doi:10.1371/journal.pone.0059740.g008
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Relationship to Previous Work–Brain Injury,
Haemorrhage, Ab, Tau and Plaques
The present evidence that a form of traumatic brain injury
(TBI, in this case a needle stick) causes haemorrhage, the co-
localised formation of plaque-like deposits and increased expres-
sion of Ab and tau in surrounding tissues, could have been
anticipated from prior studies.
In humans, closed-head TBI (typically a blow to the head) has
been reported to cause small-vessel haemorrhages (petechial
bleeding) [47,48], and to be associated with the deposition of Ab
and/or the formation of plaques [40,41,42,43,49,50,51,52,53],
hyperphosphorylated tau [35,54] and dementia [55,56,57]. In the
rat, needle stick injury has been reported previously (confirmed in
Figure 7) to induce upregulation of APP and related enzymes in
surrounding tissue [29,58]; the present observation that 4G8 and
AT8 labelling is upregulated appears to be novel. In Tg2576 mice,
repeated mild, closed-skull trauma caused the formation of Ab+
plaque-like deposits [59]. These relationships have been reported
largely separately; this study links them in an experimental test of
the idea that trauma-induced haemorrhage can induce the
formation of plaques.
Other workers have proposed other links from TBI to plaque
deposition; for example that plaque formation is mediated by
damage to tracts of nerve fibres in which trauma has induced an
upregulation of Ab [51]. The present study does contribute to
defining the link between injury and plaque formation, but
previous studies [60,61] have proposed a link in the binding of Ab
to haemoglobin, and the induction of oligomerisation of Ab which
results. As previously argued [8], this binding could be a step from
haemorrhage to plaque formation.
Plaques and ECDs–toxic Foci or Scars?
The question whether senile plaques are quiescent scars or foci
of toxicity bears on the mechanism, and therefore on the
treatment, of age-related dementia. The idea that the senile
plaque is an active site of toxicity arises from extensive evidence of
the toxicity of various forms of Ab (monomeric, oligomeric and
polymeric/insoluble), summarised in [62]. The evidence includes
studies of the interaction of Ab with other abnormal proteins
found in association with plaques, and studies of the interaction of
various metals with Ab. This evidence formed the basis for clinical
trials in which the amyloid ‘load’ of the brain was reduced, in the
hope of reducing toxicity. The trials have been disappointing,
however, though the search for an amyloid-related treatment
continues (for a sympathetic, accessible review, see [63]).
The evidence that the senile plaque is a non-toxic scar, formed
at the site of an ‘upstream’ pathology such as a small-vessel bleed,
includes evidence that plaques form around blood vessels and
contain blood specific molecules (haem, clotting factors, even red
cells) [4,5,9]; and evidence (reviewed in [8]) that ‘Alzheimer-like’
(i.e. plaques and tangles) and cerebrovascular pathologies co-occur
in many cases studied post-mortem, that the risk factors for age-
related dementia and for cardiovascular disease overlap exten-
Figure 9. Concentric organisation of human plaques. A: At low power the long-established pattern of plaques characteristic of senile dementia
is demonstrated with the 4G8 antibody. The arrow points to a series of plaques arranged in a line, along a blood vessel. B: At higher power, many
plaques show a concentric arrangement. The core is cellular, the cells often containing autofluorescent material, including lipofuscin and
hemosiderin. This core is surrounded by a shell of 4G8-labelled Ab (green), with astrocytes (GFAP-labelled, red) within and outside the cell. The blue
fluorescence is bisbenzimide labelling of nuclear DNA. C: The concentric arrangement was a common feature of plaques.
doi:10.1371/journal.pone.0059740.g009
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sively, and that oxidative stress and hypoxia are prominent in the
dementing brain. Other authors [64,65] have developed the
additional argument, that plaques may be a defensive response to
the hypoxia, oxidative stress and iron accumulation stress
prominent in the brain undergoing dementia.
The Flanking Region–a Region of Death or Survival?
Neuronal death could not, in our data, be detected in the region
flanking the needle track, in which the expression of APP, Ab and
tau was upregulated transiently by the penetrating injury; Ab
expression in these conditions appears not to be toxic. Corre-
spondingly, mature human plaques appear cellular and organised,
Figure 10. Cellular organisation of human plaques, seen in serial, thin (0.1 mm) sections. A–E are sections of one plaque, F and G of
another. A: The blue fluorescence is autofluorescence from amyloid in the plaque. It surrounds a branch point of a capillary-size vessel (v). B: 0.8 mm
away, the amyloid autofluorescence is still prominent. C: 1.0 mm from A (and 0.2 mm from B) the plaque is labelled green with the 4G8 antibody. D:
9 mm from A (in the same direction), the plaque remains clearly labelled with the 4G8 antibody. E: 4 mm from A, the same vessel (v) is apparent; small
elements of tau labelling (green) are shown, in the area of the plaque. F: Blue autofluorescence shows amyloid forming a shell surrounding red and
yellow autofluorescent bodies. Labelling for APP (green) shows punctate APP+ elements forming an incomplete shell outside the amyloid shell. G:
The blue fluorescence in this panel is bisbenzimide labelling for nuclear DNA. 4G8 labelling (green) shows Ab forming a shell around a cellular core,
which includes the vessel, some nuclei and autofluorescent material. The inset shows a vessel at the centre of the plaque, at higher power.
doi:10.1371/journal.pone.0059740.g010
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with a population of active glial cells, confirming previous reports
[66]. That is, the regions surrounding penetrating injury or
plaques do not appear to be regions of increased cell death.
What then might be the effect of the transient upregulation of
APP and Ab induced in our needle stick model, up to 500 mm
from the needle track? One clue comes from the observation of the
effect of needle stick penetration of the retina [67,68]. These
workers tested the neuroprotective effects of growth factors
injected into the vitreous humour on photoreceptor death in rat
models in which a genetic mutation or light damage caused
premature photoreceptor degeneration. Injections of fibroblast
growth factor and ciliary neurotrophic factor (CNTF) slowed the
degeneration; and sham injections which penetrated the retina
also induced a slowing of photoreceptor death over a wide region
of retina, and induced the upregulation of brain derived
neurotrophic factor and CNTF. We are currently testing whether
a penetrating wound of the brain produces a similar ‘halo of
invulnerability’, and whether that halo corresponds spatially and
temporally with the upregulation of APP, Ab, tau and other
candidate peptides and cytokines.
Limits
Several limitations of the present observations deserve note.
First, the penetrating injury model does not separate the
mechanical impact of the needle from the haemorrhage which
occurs along the track. Causal connection between haemorrhage
Figure 11. Co-localisation of haem and amyloid labelling in human neocortex. A,B: The dark material is haem, identified with the Perls
(Prussian blue) reaction, with DAB as the reporter molecule. The red labelling is Congo red, which labels amyloid. In the right hand panel the
background Congo red labelling has been reduced. The largest haem deposit is surrounded by a shell of Congo red. Smaller haem deposits co-
localise side-by-side with Congo red. C: Side-by-side co-localislation of haem and Congo red, in another plaque. D: Co-localisation of haem and
Thioflavin S (green) in several plaques.
doi:10.1371/journal.pone.0059740.g011
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and the formation of plaque-like deposits has to be argued from
additional grounds (above).
Second, the 4G8 and 6E10 antibodies are established labels for
Ab, but also label the precursor protein APP. Present observations
that labelling with these antibodies increases strongly but
transiently in tissue around the needle track indicates that Ab
expression, and perhaps its secretion by cells (neurons and glia)
near the track, are upregulated. Re-analysis with monomer-
specific antibodies is required to establish whether the cells
generate monomeric Ab.
Third, we observed that, in the rat brain, plaque-like ECDs did
not stain with Congo red or Thioflavin S, suggesting that they do
not have the same b-sheet structure as senile plaques in the human
brain. We could not therefore demonstrate the co-localisation of
haemorrhage-related iron with Congo red or Thioflavin S, as was
possible for human plaques. Nevertheless, both the Perls reaction
product and 4G8+ or 6E10+ extracellular deposits (plaques) were
tightly confined to the needle track, suggesting that the ECDs form
where the needle causes haemorrhage.
Fourth, because there are no histochemical stains for haem, we
used Perls staining for iron as a surrogate marker. While it is
possible that some of the iron observed may originate from cell
damage rather than haemorrhage, Perls staining has been
extensively used by neuropathologists to assess intracerebral
bleeding [69,70] and the close proximity of iron deposition to
blood vessels gives us confidence that this is an appropriate marker
of haemorrhage.
Vasculopathy vs Proteopathy
Finally, comment is appropriate on the logical relationship
between apparently competing ideas of the pathogenesis of
Alzheimer’s dementia, which suggest that the dementia is due
on the one hand to cerebrovascular disease [4,8,9,15] and,
conversely, that the condition is a proteopathy, caused by the
formation of toxic forms of proteins [71,72].
At first glance, the two proposals appear mutually exclusive; but
haemorrhage induces hypoxia and hypoxia upregulates Ab
expression, and may induce an amyloid proteopathy. De la
Torre’s emphasis [44] on ischaemia caused by capillary hypo-
function seems distinct from the haemorrhage hypothesis tested
here, but if cerebral ischaemia can induce haemorrhage [73], the
two ideas converge. We would still emphasise that only the
capillary haemorrhage idea can account for the distribution, size
and features of plaques [8], but a fair reading of the evidence does
not, we suggest, lead to the exclusion of any of these ideas. What is
at issue is the pathogenesis of plaques, and whether it begins with
vascular breakdown.
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